Ellis W.T. Wong

Suppression of PTEN function increases breast cancer chemotherapeutic drug resistance while conferring sensitivity to mTOR inhibitors

Linda S. Steelman, Patrick M. Navolanic, Melissa L. Sokolosky et al. · Oncogene · 2008 · 171 citations · Full text

Breast Oncology, Pten Function Increases, Medicine +7

The Raf/MEK/ERK pathway can govern drug resistance, apoptosis and sensitivity to targeted therapy

Stephen L. Abrams, Linda S. Steelman, John G. Shelton et al. · Cell Cycle · 2010 · 136 citations · Full text

Drug Resistant Cells, Chemoprevention Strategy, Apoptosis +16

Involvement of Akt and mTOR in chemotherapeutic- and hormonal-based drug resistance and response to radiation in breast cancer cells

Linda S. Steelman, Patrick M. Navolanic, William H. Chappell et al. · Cell Cycle · 2011 · 91 citations · Full text

Targeting the RAF/MEK/ERK, PI3K/AKT and P53 pathways in hematopoietic drug resistance

James A. McCubrey, Linda S. Steelman, Richard A. Franklin et al. · Advances in Enzyme Regulation · 2007 · 90 citations · Full text

Tumor Biology, Hematopoietic Drug Resistance, Medicine +7

Involvement of p53 and Raf/MEK/ERK pathways in hematopoietic drug resistance

James A. McCubrey, Stephen L. Abrams, Giovanni Ligresti et al. · Leukemia · 2008 · 80 citations

Tumor Biology, Medicine, Receptor Tyrosine Kinase +6